Scarica l'app Stockscreener
2.44
1.61%
-0.04
Pre-mercato:
2.56
0.12
+4.92%
Precedente Chiudi:
$2.48
Aprire:
$2.51
Volume 24 ore:
74,620
Relative Volume:
0.52
Capitalizzazione di mercato:
$74.75M
Reddito:
$6.21M
Utile/perdita netta:
$-19.92M
Rapporto P/E:
-2.3238
EPS:
-1.05
Flusso di cassa netto:
$-16.76M
1 W Prestazione:
+1.24%
1M Prestazione:
-1.41%
6M Prestazione:
-13.78%
1 anno Prestazione:
-16.72%
Intervallo 1D:
$2.34
$2.55
Intervallo di 1 settimana:
$2.34
$2.58
Portata 52W:
$1.99
$3.798
InspireMD Inc. Stock (NSPR) Company Profile
Nome
InspireMD Inc.
Settore
Industria
Telefono
972 3 6917691
Indirizzo
4 Menorat Hamaor Street, Tel Aviv
Confronta NSPR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
2.44 | 76.89M | 6.21M | -19.92M | -16.76M | -1.05 |
|
ABT
Abbott Laboratories
|
125.64 | 218.92B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.21 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
396.66 | 153.22B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.32 | 117.89B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
75.80 | 45.12B | 5.54B | 4.18B | 623.10M | 7.00 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2016-01-07 | Iniziato | Rodman & Renshaw | Buy |
| 2015-03-13 | Downgrade | Oppenheimer | Outperform → Perform |
| 2013-11-26 | Iniziato | Oppenheimer | Outperform |
InspireMD Inc. Borsa (NSPR) Ultime notizie
How MSGS stock compares to its top competitorsIs InspireMD Inc. stock undervalued or overvalued nowUnbelievable profit margins - jammulinksnews.com
What analysts say about InspireMD Inc. stockRapid wealth multiplication - Autocar Professional
What drives InspireMD Inc. stock pricePhenomenal investment performance - Autocar Professional
Is InspireMD Inc. a good long term investmentConsistent triple returns - jammulinksnews.com
InspireMD Inc. Stock Analysis and ForecastAccelerated capital growth - jammulinksnews.com
How InspireMD Inc. stock performs during market volatilityShort Term Risk Controlled Alerts - Newser
InspireMD to Announce Second Quarter 2025 Financial Results - The Manila Times
InspireMD, Inc. Schedules Release of Second Quarter 2025 Financial Results and Conference Call - Nasdaq
Brown Advisory Inc. Takes $27,000 Position in InspireMD, Inc. (NYSE:NSPR) - Defense World
InspireMD Shares Rise on U.S. Rollout of CGuard Prime Carotid Stent - MSN
InspireMD Launches CGuard Prime Carotid Stent System in the U.S. - MSN
What makes InspireMD Inc. stock price move sharplyInvestor Favorite Picks - Newser
Why InspireMD Inc. stock attracts strong analyst attentionFree Access to Investment Community - Newser
InspireMD Launches CGuard Prime Stent in U.S. Market - The Globe and Mail
InspireMD launches CGuard Prime carotid stent in US after FDA approval By Investing.com - Investing.com South Africa
InspireMD Launches Carotid Stent System for the Preventing Strokes - Diagnostic and Interventional Cardiology
InspireMD stock rises after US commercial launch of carotid stent system - Investing.com Nigeria
InspireMD stock rises after US commercial launch of carotid stent system By Investing.com - Investing.com South Africa
InspireMD Announces U.S. Commercial Launch of CGuard® Prime Carotid Stent System for the Prevention of Stroke - The Manila Times
InspireMD launches CGuard Prime carotid stent in US after FDA approval - Investing.com
NSPR launches CGuard Prime in U.S.; 8-K filed with Exhibit 99.1 | NSPR SEC FilingForm 8-K - Stock Titan
InspireMD, Inc.(NasdaqCM: NSPR) added to Russell 3000E Index - MarketScreener
InspireMD, Inc.(NasdaqCM: NSPR) added to Russell 3000E Value Index - MarketScreener
Why Did InspireMD Plunge 10.71% Despite FDA Approval? - AInvest
InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke - GlobeNewswire
InspireMD Inc. Azioni (NSPR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.03%
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):